Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Viveve Medical Inc.
(VIVE:NASDAQ)
Viveve Announces Regulatory Approval for Viveve System in Mexico (10/17/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Bayer to Sell Select Business Lines to Close Monsanto Buyout (10/16/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada (10/16/2017)
view
Celgene Corp.
(CELG:NASDAQ)
The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene (10/17/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Immune Design's Sarcoma Candidate to Enter Phase III in 2018 (10/17/2017)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Notified By FDA That It Can Proceed With Phase 2B Investigational New Drug Clinical Trial For Osteoarthritis Of The Knee (10/17/2017)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Warns Of Fake Emails (10/17/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Announces Third Quarter 2017 Financial Results (10/17/2017)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in Advanced Bladder Cancer (10/16/2017)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Announces Release Date for 2017 Third Quarter Results (10/16/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS (10/16/2017)
view